In advanced endometrial cancer, primary cytoreductive surgery is associated with superior oncologic outcomes compared with other treatment modalities. Mariam AlHilli, MD, explains why it is recommended for first-line management, if feasible.
Sleep interventions may help improve quality of life of patients with both endometrial cancer and obesity, a new Case Comprehensive Cancer Center study finds. Co-authors Jay Alberts, PhD, and Chad Michener, MD, explain.
Gynecologic oncologist Mariam AlHilli, MD, explains recent research, which confirms that women under 40 with endometrial cancer have more favorable prognoses, though are more likely to recur. The study also found that mismatch repair protein deficiency caused by methylation of the gene MLH1 predicted a worse prognosis.
Delayed time-to-surgery has a negative impact on overall survival of women with early stage endometrial cancer, a recent study reveals. Contributors to delay include race, insurance status and facility type. Additional contributors may include increased frequency of preoperative diagnostic testing, individual surgeon case load, lack of surgeon access to a robotic surgery platform, or availability of specialist gynecologic oncologists.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
When endometrial cancer is diagnosed, accurate staging and treatment techniques optimize patient outcomes. Learn how minimally invasive staging is improving accuracy while reducing complications.
Universal screening for endometrial cancer, begun in 2012 at Cleveland Clinic, has helped build one of the largest prospective cohorts of screened patients, providing fertile ground for studying Lynch syndrome.
Cleveland Clinic researchers discover a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much-needed new therapies for women with limited options.
A Cleveland Clinic study of patients with some features of Cowden syndrome and endometrial cancer shows that certain demographic and clinical features can predict the likelihood of harboring a PTEN or other gene mutation and serve as a catalyst for cancer genetic evaluation.